Description

BSE lists new Commercial Paper of Rs. 250 crore issued by Vivriti Capital Limited on private placement basis, with trading commencing October 27, 2025.

Summary

BSE has listed new Commercial Paper issued by Vivriti Capital Limited on private placement basis. The securities, valued at Rs. 5,00,000 each with a total quantity of 500 units (Rs. 250 crore aggregate), are admitted to trading on the BSE Debt segment effective October 27, 2025. The instrument carries a CRISIL A1+ rating and matures on April 22, 2026.

Key Points

  • Issuer: Vivriti Capital Limited
  • Security Type: Commercial Paper (Private Placement)
  • Face Value: Rs. 5,00,000 per unit
  • Quantity Issued: 500 units
  • Total Issue Size: Rs. 250 crore
  • Issue Price: Rs. 477,961.50 per unit
  • Scrip Code: 730439
  • Scrip ID: VCL241025
  • ISIN: INE01HV14AC7
  • Credit Rating: CRISIL A1+
  • Market Lot: 1 unit
  • Trading Denomination: Rs. 5 lakhs and multiples
  • Tick Size: 1 paise
  • Issuing and Paying Agent: The Federal Bank Ltd

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE01HV14AC7
  • Trading permitted only in standard denomination of Rs. 5 lakhs and multiples thereof
  • Members requiring clarification should contact BSE debt department on 22728352/8597/8995/5753/8915

Important Dates

  • Allotment Date: October 24, 2025
  • Listing Date: October 27, 2025
  • Redemption Date: April 22, 2026
  • Notice Date: October 27, 2025

Impact Assessment

Minimal market impact. This is a routine commercial paper listing in the debt segment affecting only institutional investors and trading members dealing in short-term debt instruments. The instrument has a maturity period of approximately 6 months and provides a short-term funding avenue for Vivriti Capital Limited. No impact on equity markets or retail investors.

Impact Justification

Routine commercial paper listing with no impact on equity markets or broader trading operations. Affects only debt segment participants dealing with this specific instrument.